Shannon N. Westin
ORCID: 0000-0002-1922-0156
· 4 papers in corpus
PURPOSE: We aimed to describe RAS mutations in gynecologic cancers as they relate to clinicopathologic and genomic features, survival, and therapeutic implications. EXPERIMENTAL DESIGN: Gynecologic cancers with available somatic molecular …
Although endometrial cancer management remains challenging, a deeper understanding of the genetic diversity as well as the drivers of the various pathogenic states of this disease has led to development of divergent management approaches in…
10082 Background: Pelvic exenteration (PE) is surgical procedure associated with significant morbidity offered to select women with centrally recurrent gynecologic cancers. This ongoing study aims to examine multifaceted quality of life (QO…